N/A N=9 Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings
Covid19 · Diabetes Mellitus
Primary: Time in Range — 21.6 percentage of time
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=116 The Effects of Cognitive Behavioral Therapy and Transcranial Current Stimulation (tDCS) on Chronic Lower Back Pain
Chronic Low Back Pain · Opioid Use, Unspecified
Primary: Average Daily Pain — 5.41; 5.96 score on a scale
N/A N=139 Stepped Care for Depression in Heart Failure
Heart Failure · Depressive Disorder, Major
Primary: Beck Depression Inventory (BDI-2) Total Score — 15.6; 19.6 score on a scale
N/A N=28 Chronic Liver Disease in Urea Cycle Disorders
Urea Cycle Disorder
Primary: Liver Stiffness as Measured by Shear Wave Elastography — 13; 14 Participants
Phase 2 N=114 NSAID Effects on Clinical and Imaging Breast Biomarkers
Inflammation · Cancer · Pain
Primary: Change in Breast Density Measured as Fat to Water Ratio by Magnetic Resonance Imaging — -9.8; -3.6 percent change in breast density — p=<0.05
Early Phase 1 N=22 Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent
Chronic Pain · Opiate Dependence · Lower Back Pain
Primary: Change in Quantitative Pain Testing Following Active TMS Compared to Baseline — 1.4; .3 Change from Baseline (degrees C) — p=.83
N/A N=406 DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
Breast Cancer
Primary: Pathologic Complete Response (pCR) — 71; 70; 63; 156 Participants — p=0.484
N/A N=99 Cryoanalgesia to Prevent Acute and Chronic Pain Following Surgery: A Randomized, Double-Masked, Sham-Controlled Study
Mastectomy · Upper Limb Amputation Below Elbow · Upper Limb Amputation Above Elbow
Primary: Average Pain (Mastectomy Subjects Only) — 0.0; 3.0 score on a scale
N/A N=110 Weight Management for Adolescents With IDD
Developmental Disabilities · Weight Loss · Body Weight
Primary: Weight Change at 6 Months — -0.3; -1.8; -5.0 kg
Phase 3 N=17 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Pediatric Heart Failure
Primary: Part 1: Pharmacokinetics of LCZ696 Analytes (Sacubitril, LBQ657, and Valsartan): Maximum Drug Concentration in Plasma (Cmax) — 523; 179; 1970; 549 nanograms per…
N/A N=6,350 Universal HIV Screening and Targeted HCV Screening in Emergency Department
Hepatitis C · Hiv
Primary: Prevalence — 78; 118; 2; 9 Participants
Phase 2 N=42 Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response
Heart Failure
Primary: VO2peak — 17.7; 18.0 mL/kg/min
Phase 2 N=21 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Primary: Change From Baseline in Peak Oxygen Uptake (VO2 Max) at 24 Weeks — 1.28 mL/min/kg
Phase 2 N=6 A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib
HER2 Amplified Breast Cancer
Primary: Changes in Colon Pathology — 2; 2 participants
N/A N=41 Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study
Opioid-use Disorder
Primary: Mean Medication Possession Ratio — 0.839; 0.752 Medication supply / days in time period